Rare diseases
Investigational molecules
Locations
Oficinas 3 4 5, Calle De Santa Balbina 2, 28023 Madrid, Spain
Research activity in acute myeloid leukemia centers on newly diagnosed adults with limited fitness for intensive treatment, including older patients and those with IDH1 mutation. The portfolio includes interest in venetoclax-based combinations, azacitidine, low-dose cytarabine, quizartinib, and ivosidenib, with attention to remission depth and survival outcomes.
The sponsor’s leukemia studies also include treatment approaches for patients who are not candidates for standard induction chemotherapy.
Fundacion PETHEMA runs clinical trials in conditions such as Plasma cell myeloma, Acute myeloid leukaemia, Chronic lymphocytic leukaemia, B-cell small lymphocytic lymphoma, among others.
Clinical trials run by this sponsor – those enrolling participants first.
PortugalSpainSpainSpainSpainSpainSpainSpainSpainSpainSpainSpainIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
